CohBar Inc
(NASDAQ : CWBR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.81%89.371.3%$810.51m
AMGNAmgen Inc.
1.48%188.251.2%$638.32m
GILDGilead Sciences, Inc.
0.50%65.880.9%$484.72m
BIIBBiogen Inc.
0.84%323.871.3%$431.04m
ILMNIllumina, Inc.
1.31%300.773.5%$315.43m
REGNRegeneron Pharmaceuticals, Inc.
0.70%421.532.6%$292.20m
VRTXVertex Pharmaceuticals Incorporated
0.97%184.841.9%$256.05m
ALXNAlexion Pharmaceuticals, Inc.
0.92%128.722.0%$221.69m
SRPTSarepta Therapeutics, Inc.
1.51%138.6015.4%$154.63m
AAgilent Technologies, Inc.
0.04%77.921.6%$150.86m
EXASExact Sciences Corporation
9.04%90.8125.3%$144.24m
INCYIncyte Corporation
1.13%84.272.5%$113.20m
ARRYArray BioPharma Inc.
3.30%23.468.2%$111.58m
EXELExelixis, Inc.
0.71%21.376.4%$82.65m
NBIXNeurocrine Biosciences, Inc.
1.80%78.705.1%$78.61m

Company Profile

CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Pasadena, CA.